• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿霉素和柔红霉素对小鼠巨噬细胞的体外和体内细胞毒性。

In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.

作者信息

Mantovani A

出版信息

Cancer Res. 1977 Mar;37(3):815-20.

PMID:837378
Abstract

In virto exposure of murine lymphoma cells to adriamycin and daunomycin (DM) for 24 hr resulted in comparable cytotoxicity as assessed by viable cell counts and inhibition of DNA synthesis. The spontaneous DNA synthesis of spleen lymphocytes in vitro was also equally affected by the two agents. However, when the in vitro effects of the two drugs on macrophage monolayers were investigated, DM was found to be at least four times more toxic than AM. In vivo-administered DM was more suppressive than AM of Corynebacterium parvum-induced spleen macrophage cytotoxicity. The fact that DM is less effective than AM as a cancer chemotherapeutic agent in vivo may actually be due to the greater destruction of macrophages by DM and a resultant reduction in the contribution of host immunity to the anti-tumor action.

摘要

将鼠淋巴瘤细胞在体外暴露于阿霉素和柔红霉素(DM)24小时,通过活细胞计数和DNA合成抑制评估,结果显示二者具有相当的细胞毒性。这两种药物对体外脾淋巴细胞的自发DNA合成也有同等影响。然而,当研究这两种药物对巨噬细胞单层的体外作用时,发现DM的毒性至少是阿霉素(AM)的四倍。在体内给予时,DM对短小棒状杆菌诱导的脾巨噬细胞细胞毒性的抑制作用比AM更强。DM作为一种癌症化疗药物在体内不如AM有效的事实,实际上可能是由于DM对巨噬细胞的破坏更大,导致宿主免疫对抗肿瘤作用的贡献降低。

相似文献

1
In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.阿霉素和柔红霉素对小鼠巨噬细胞的体外和体内细胞毒性。
Cancer Res. 1977 Mar;37(3):815-20.
2
Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.宿主防御机制在阿霉素和柔红霉素对小鼠的抗肿瘤活性中的作用。
J Natl Cancer Inst. 1979 Jul;63(1):61-6.
3
Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.在用阿霉素或柔红霉素处理脾脏供体小鼠后,培养物中主要细胞介导的免疫增强。
Cancer Res. 1977 Jun;37(6):1719-26.
4
Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.短小棒状杆菌单独及与阿霉素联合应用在实验性肿瘤系统中的作用。
Cancer Treat Rep. 1976 Jul;60(7):823-8.
5
Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells.
J Natl Cancer Inst. 1979 Aug;63(2):423-6.
6
Possible mechanisms underlying the induction of cytotoxic macrophages by Corynebacterium parvum: in vitro induction of cytotoxicity in normal macrophages by immune lymphocytes.
J Reticuloendothel Soc. 1978 Oct;24(4):339-49.
7
Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.巨噬细胞在肿瘤免疫中的作用。I. 巨噬细胞与淋巴细胞在同基因肿瘤免疫中的协作。
Immunology. 1972 Oct;23(4):615-26.
8
Adriamycin-activated macrophages as tumor growth inhibitors.阿霉素激活的巨噬细胞作为肿瘤生长抑制剂。
Cancer Res. 1981 Oct;41(10):3852-6.
9
The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.
Cancer Res. 1975 May;35(5):1175-81.
10
A characterization of the immunosuppressive activity of adriamycin and daunomycin on humoral antibody production and tumor allograft rejection.阿霉素和柔红霉素对体液抗体产生及肿瘤同种异体移植排斥反应的免疫抑制活性特征
Cancer Res. 1976 Apr;36(4):1222-7.

引用本文的文献

1
Follicular lymphoma and macrophages: impact of approved and novel therapies.滤泡性淋巴瘤与巨噬细胞:已获批疗法和新型疗法的影响。
Blood Adv. 2021 Oct 26;5(20):4303-4312. doi: 10.1182/bloodadvances.2021005722.
2
Wandering pathways in the regulation of innate immunity and inflammation.固有免疫和炎症调节中的游走通路。
J Autoimmun. 2017 Dec;85:1-5. doi: 10.1016/j.jaut.2017.10.007. Epub 2017 Oct 25.
3
Tissue transport affects how treatment scheduling increases the efficacy of chemotherapeutic drugs.组织转运影响治疗方案的安排如何提高化疗药物的疗效。
J Theor Biol. 2018 Feb 7;438:21-33. doi: 10.1016/j.jtbi.2017.10.022. Epub 2017 Oct 21.
4
Microfluidic technique to measure intratumoral transport and calculate drug efficacy shows that binding is essential for doxorubicin and release hampers Doxil.微流控技术测量肿瘤内转运并计算药物疗效表明,阿霉素的结合是必需的,而释放则会阻碍 Doxil 的作用。
Integr Biol (Camb). 2013 Sep;5(9):1184-96. doi: 10.1039/c3ib40021b.
5
Analysis of therapeutic effect in experimental chemoimmunotherapy for rat ascites tumor.大鼠腹水瘤实验性化学免疫治疗的疗效分析
Cancer Immunol Immunother. 1982;14(2):67-72. doi: 10.1007/BF00200169.
6
Adriamycin-induced activation of NK activity may initially involve LAF production.阿霉素诱导的自然杀伤细胞活性激活可能最初涉及淋巴激活因子的产生。
Cancer Immunol Immunother. 1983;15(3):188-93. doi: 10.1007/BF00199163.
7
The synergistic tumoricidal activity of anticancer drugs and oxidative burst-triggered macrophages.抗癌药物与氧化爆发触发的巨噬细胞的协同杀肿瘤活性。
Cancer Immunol Immunother. 1985;20(3):205-8. doi: 10.1007/BF00205577.
8
Cancer chemotherapeutics as immunomodulators.作为免疫调节剂的癌症化疗药物。
Springer Semin Immunopathol. 1985;8(4):361-74. doi: 10.1007/BF01857390.
9
Cytolytic T lymphocytes and antibodies to myocytes in adriamycin-treated BALB/c mice. Evidence for immunity to drug-induced antigens.阿霉素处理的BALB/c小鼠中的细胞毒性T淋巴细胞和抗心肌细胞抗体。对药物诱导抗原免疫的证据。
Am J Pathol. 1992 Jan;140(1):233-42.
10
Immunodepressive activity of FCE 23762 on humoral and cell-mediated immune responses in normal mice: comparison with doxorubicin.FCE 23762对正常小鼠体液免疫和细胞介导免疫反应的免疫抑制活性:与阿霉素的比较。
Agents Actions. 1992 Nov;37(3-4):311-8. doi: 10.1007/BF02028125.